Vertex Pharmaceuticals
VRTX
NASDAQ
IPO1991
about VRTX
Vertex Pharmaceuticals is a biotechnology company dedicated to developing life-saving medicines, particularly for cystic fibrosis and other rare diseases, by targeting the underlying genetic causes rather than just symptoms.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $396.17 | $396.86 | $387.19 | $101.34B | 1.51M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$4.02 | n/a | 34.60 | 38.83% | 34.84% | 0% |